Zydus Cadila’s antiviral drug for moderate COVID-19 disease gets emergency use approval
“A single dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients. When administered
Read More“A single dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients. When administered
Read More“Both Covishield vaccinated sera and convalescent sera were found to offer protection against the double mutant variant (B.1.617),” says Dr.
Read More